ScholarIQanswers from OpenAlex
Tokyo Institute of Psychiatry
InstitutionResearch output, impact & collaborations
Tokyo Institute of Psychiatry is a institution indexed in ScholarIQ from OpenAlex.
What is known about Tokyo Institute of Psychiatry?
ScholarIQrecord summary
Tokyo Institute of Psychiatry is a research organisation in Tokyo, JP. OpenAlex records 3,105 works and 226,237 citations for it. 828 researchers list it as their most recent affiliation.
How many works does Tokyo Institute of Psychiatry have?
ScholarIQindexed works
Tokyo Institute of Psychiatry has 3,105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tokyo Institute of Psychiatry have?
ScholarIQcitation count
Tokyo Institute of Psychiatry has 226,237 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Tokyo Institute of Psychiatry?
ScholarIQresearcher count
Tokyo Institute of Psychiatry has 828 researchers in the ScholarIQ index.
What is the average h-index at Tokyo Institute of Psychiatry?
ScholarIQavg h-index
Tokyo Institute of Psychiatry has an average h-index of 54 in OpenAlex.
What is the ROR of Tokyo Institute of Psychiatry?
ScholarIQror
The ROR for Tokyo Institute of Psychiatry is on the source record.
What is the OpenAlex record for Tokyo Institute of Psychiatry?
ScholarIQopenalex
The OpenAlex for Tokyo Institute of Psychiatry is on the source record.
Who are the most-cited researchers behind Tokyo Institute of Psychiatry?
ScholarIQtop researchers by citations
What are the most-cited papers on Tokyo Institute of Psychiatry?
ScholarIQmost cited works
International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity
Capucine Pïcard, H. Bobby Gaspar, Waleed Al–Herz, Aziz Bousfiha, Jean‐Laurent Casanova, Talal A. Chatila, Yanick J. Crow, Charlotte Cunningham‐Rundles, Amos Etzioni, José Luis Franco, Steven M. Holland, Christoph Klein, Tomohiro Morio, Hans D. Ochs, Éric Oksenhendler, Jennifer M. Puck, Mimi L.K. Tang, Stuart G. Tangye, Troy R. Torgerson, Kathleen E. Sullivan
Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity
Yoshiyuki Minegishi, Masako Saitō, Tomohiro Morio, Ken Watanabe, Kazunaga Agematsu, Shigeru Tsuchiya, Hidetoshi Takada, Toshiro Hara, Nobuaki Kawamura, Tadashi Ariga, Hideo Kaneko, Naomi Kondo, Ikuya Tsuge, Akihiro Yachie, Yukio Sakiyama, Tsutomu Iwata, Fumio Bessho, Tsutomu Oh‐ishi, Kosuke Joh, Kohsuke Imai, Kazuhiro Kogawa, Miwa Shinohara, Mikiya Fujieda, Hiroshi Wakiguchi, Srdjan Pašić, Mario Abinun, Hans D. Ochs, Eleonore D. Renner, Annette Jansson, Bernd H. Belohradsky, Ayşe Metìn, Norio Shimizu, Shuki Mizutani, Toshio Miyawaki, Shigeaki Nonoyama, Hajime Karasuyama
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina García-Prat, Lucy Bizien, Alba Parra-Martínez, Rui Yang, Liis Haljasmägi, Mélanie Migaud, Karita Särekannu, Julia Maslovskaja, Nicolas de Prost, Yacine Tandjaoui-Lambiotte, Charles‐Édouard Luyt, Blanca Amador-Borrero, Alexandre Gaudet, Julien Poissy, Pascal Morel, Pascale Richard, Fabrice Cognasse, Jesús Troya, Sophie Trouillet‐Assant, Alexandre Bélot, Kahina Saker, Pierre Garçon, Jacques G. Rivière, Jean‐Christophe Lagier, Stéphanie Gentile, Lindsey B. Rosen, Elana Shaw, Tomohiro Morio, Junko Tanaka, David Dalmau, Pierre‐Louis Tharaux, D. Sène, Alain Stépanian, Bruno Mégarbane, Vasiliki Triantafyllia, Arnaud Fekkar, James R. Heath, José Luis Franco, Juan‐Manuel Anaya, Jordi Solé‐Violán, Luisa Imberti, Andrea Biondi, Paolo Bonfanti, Riccardo Castagnoli, Ottavia M. Delmonte, Yu Zhang, Andrew L. Snow, Steven M. Holland, Catherine M. Biggs, Marcela Moncada‐Vélez, Andrés A. Arias, Lazaro Lorenzo, Soraya Boucherit, Boubacar Coulibaly, Dany Anglicheau, Anna M. Planas, Filomeen Haerynck, Sotiriјa Duvlis, Robert L. Nussbaum, Tayfun Özçelık, Sevgi Keleş, Ahmed Aziz Bousfiha, Jalila El Bakkouri, Carolina Ramı́rez-Santana, Stéphane Paul, Qiang Pan‐Hammarström, Lennart Hammarström, Annabelle Dupont, Alina Kurolap, Christine N. Metz, Alessandro Aiuti, Giorgio Casari, Vito Lampasona, Fabio Ciceri, Lucila Akune Barreiros, Elena Domínguez‐Garrido, Mateus Vidigal, Mayana Zatz, Diederik van de Beek, Sabina Sahanic, Ivan Tancevski, Yuriy Stepanovskyy, Oksana Boyarchuk, Yoko Nukui, Miyuki Tsumura, Loreto Vidaur, Stuart G. Tangye, Sonia Burrel, Darragh Duffy, Lluís Quintana‐Murci, Adam Klocperk
The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies
Aziz Bousfiha, Leïla Jeddane, Capucine Pïcard, Fatima Ailal, H. Bobby Gaspar, Waleed Al–Herz, Talal A. Chatila, Yanick J. Crow, Charlotte Cunningham‐Rundles, Amos Etzioni, José Luis Franco, Steven M. Holland, Christoph Klein, Tomohiro Morio, Hans D. Ochs, Éric Oksenhendler, Jennifer M. Puck, Mimi L.K. Tang, Stuart G. Tangye, Troy R. Torgerson, Jean‐Laurent Casanova, Kathleen E. Sullivan
A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia
Isa Okajima, Yoko Komada, Yuichi Inoue
How much of the research on Tokyo Institute of Psychiatry is open access?
ScholarIQopen access share
67%OPEN ACCESS